Led by Director Dr Metodi Metodiev, the unit has uncovered a panel of protein biomarkers which could lead to improved diagnosis of tumour types and fine-tuned treatment.
‘When we set up the Proteomics Unit here we immediately turned our attention to human issues and the treatment of disease,’ said Dr Metodiev.
Each year more than 42,000 people in the UK are diagnosed with breast cancer, 99 per cent of whom are women. Research has highlighted several risk factors associated with the disease, but better markers are needed for diagnosis, prognosis and therapy. The new technology of proteomics, which is the large-scale study of proteins which are vital components of living organisms as well as tumours, promises to deliver breakthroughs into cancer biomarkers.
‘With proteomics, analysis that took a month to perform can now be done in a second. This gives us a lot more information and is bringing about a very significant change to the way we approach cancer,’ said Dr Metodiev.
Working with Dr Louise Alldridge from Anglia Ruskin University, Chelmsford, clinicians from Broomfield Hospital, Chelmsford, and the Breast Unit at Chelmsford and Essex Hospital, the scientists have examined thousands of proteins in tumour and normal human tissue. They have determined a panel of prospective biomarkers and are now narrowing it down to see what patterns emerge, before a large scale clinical trial can be attempted.
Kate Clayton | alfa
NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases
Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.
Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...
16.03.2018 | Event News
13.03.2018 | Event News
08.03.2018 | Event News
16.03.2018 | Earth Sciences
16.03.2018 | Physics and Astronomy
16.03.2018 | Life Sciences